SHORTList
HealthTech
Biotech/Pharma
Data/Analytics

Evvy

Precision women's health and microbiome diagnostics

CORE INFO

$60M+
Total Funding
Series B
Round
2020
Founded
11-50
Team Size
New York, NY
Headquarters

Evvy sells at-home vaginal and urinary tests, clinician-reviewed care, and related health products to consumers. Healthcare providers can also order tests, review results, and access treatment support through its provider tools.

  • Series B: $40 million led by Catalio Capital Management on September 15, 2026, to expand women's-health research and its vaginal-microbiome data platform.techcrunch.com
  • Traction: More than 100,000 U.S. patients and 3,000 practitioners, according to TechCrunch's 2026 coverage.techcrunch.com
  • TechCrunch reported that Evvy has produced 15 peer-reviewed publications and abstracts, launched EvvyAI, and entered fertility research.techcrunch.com

WHY WE WOULD WORK AT EVVY

Close the Gender Gap

Help advance Evvy's mission to close the gender health gap by turning overlooked female biomarkers—starting with the vaginal microbiome—into better care.

Work at the Scientific Edge

Build with metagenomic sequencing that analyzes 700+ bacteria and fungi, PCR-based UTI testing, resistance-gene detection, and EvvyAI.

Reach Real Patients

Your work can improve care for a growing community of 100,000+ patients and 3,000 practitioners using Evvy's diagnostics and clinical tools.

Unlock Better Biomarkers

Explore a proprietary dataset spanning 150,000+ vaginal microbiome samples and 200+ clinical data fields to study BV, fertility, IVF, menopause, and recurrent UTIs.

Build Across Healthcare

Work across consumer diagnostics, clinician-reviewed care, provider software, probiotics, and biotech research—not just a single test or product.

Grow With Strong Backing

Join a Series B company with $60M+ raised and fresh funding supporting research validation, EvvyAI, fertility work, and broader distribution through doctors' offices.

MARKET AND TRACTION

GROWTH TACTICS

  • Expanding from direct-to-consumer vaginal testing into urinary diagnostics, clinician-reviewed care, subscriptions, probiotics, symptom-relief products, and provider tools.

  • Building a research and biomarker-discovery platform from opted-in patient data, while expanding into fertility research, doctor's-office distribution, and EvvyAI.

    • KEY METRICS

    ✦ KEY METRIC
  • Evvy reports more than 100,000 patients and 3,000 practitioners, indicating traction across both consumer and clinical channels.

  • The company has raised approximately $60M+ across publicly reported equity rounds, including a $40M Series B announced in September 2026.

    • COMPETITIVE ADVANTAGE

    ✦ KEY METRIC
  • Evvy combines metagenomic sequencing of more than 700 bacteria and fungi with clinician-reviewed interpretation, personalized treatment recommendations, and health coaching.

  • Its proprietary vaginal-microbiome dataset supports biomarker discovery, precision care, and research across conditions including bacterial vaginosis, fertility, IVF, menopause, recurrent UTIs, and infertility.

    • MARKET POSITION

  • Evvy operates at the intersection of women's health, biotechnology, consumer healthcare, clinical diagnostics, precision medicine, and microbiome research.

  • The company positions itself as a precision women's-health platform built around vaginal-microbiome data rather than solely as an at-home testing company.

    • PRODUCT AND TECH

    Vaginal Microbiome Testing

    Evvy's at-home Vaginal Health Test uses metagenomic next-generation sequencing to analyze more than 700 bacteria and fungi. The results provide a detailed view of vaginal microbiome composition for personalized care and research.

    UTI+ PCR Diagnostics

    Evvy UTI+ is an at-home urine PCR test detecting 12 urinary pathogens and seven antibiotic-resistance genes. It supports targeted treatment recommendations and faster clinical decision-making.

    Clinician-Reviewed Care

    Evvy combines laboratory results with clinician review, personalized treatment recommendations, prescription care, and health coaching. Its platform incorporates more than 200 clinical data fields to support individualized care pathways.

    EvvyAI Data Platform

    EvvyAI applies AI, bioinformatics algorithms, and the company's proprietary vaginal-microbiome dataset to biomarker discovery and precision-care development. The platform supports research into bacterial vaginosis, fertility, IVF, menopause, recurrent UTIs, and infertility.

    Provider Testing Tools

    Evvy's provider portal enables clinicians to order tests, receive results, access interpretation materials, and obtain treatment support. It extends Evvy's diagnostics and microbiome insights into clinical workflows.

    COMPANY CULTURE

    Values

  • Close the gender health gap

  • Empower patients with data-driven insights

  • Advance inclusive women's-health research

  • Destigmatize vaginal and reproductive health

    • Operating Principles

  • Lead with science and evidence

  • Build personalized rather than one-size-fits-all care

  • Center patient trust and informed consent

  • Collaborate closely with clinicians and researchers

    • Work Style

  • Interdisciplinary collaboration across science, medicine, design, data, and operations

  • Mission-driven work in a startup environment

  • Combine consumer healthcare with biotechnology and research

  • Use patient data responsibly to support precision care

    • Learning & Growth

  • Investigate overlooked female biomarkers

  • Translate microbiome research into better diagnostics and treatments

  • Expand research across BV, fertility, IVF, menopause, UTIs, and infertility

  • Contribute to EvvyAI and biomarker-discovery initiatives